Cannabinoid receptor 2 agonist, lenabasum, for the treatment of pulmonary exacerbations in cystic fibrosis.
West NE, Konstan MW, Flume PA, VanDevanter DR, Magaret A, Mazurek H, Amelina EL, Laki I, Chiron R, Sutharsan S, Columbo C, Dorkin HL, Downey D, Sole A, Hjelte L, Tullis E, Dgetluck N, Dinh Q, Constantine S, White B, Elborn JS, Chmiel JF; JBT101-CF-002 Study Group.
West NE, et al. Among authors: columbo c.
J Cyst Fibros. 2025 May 26:S1569-1993(25)00111-0. doi: 10.1016/j.jcf.2025.03.015. Online ahead of print.
J Cyst Fibros. 2025.
PMID: 40425421